• Users Online: 578
  • Print this page
  • Email this page

  Download PDF

Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of a Phase III randomized trial to compare the benefit of gefitinib versus pemetrexed/carboplatin for epidermal growth factor receptor-mutated non-small cell lung cancer

Download fre pdf Download for citation manager
This is a temporary file and hence do not link it from a website, instead link the URL of this page if you wish to link the PDF file.
To read this article you will require Adobe© Acrobat Reader, if you do not have this installed you can download it from here


Support open access
Recommend
Recommend this journal

 
Subscribe
Subscribe onlinePayments through